Hepatic arterial infusion chemotherapy (HAIC) plus Lenvatinib and PD-1 inhibitors versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma

Hepatic arterial infusion chemotherapy (HAIC) plus Lenvatinib and PD-1 inhibitors versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma

Abstract Background Unresectable intrahepatic cholangiocarcinoma (iCCA) is characterized with dismal prognosis. Here, this study aimed to compare the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) combined with lenvatinib and PD-1 inhibitors versus systemic chemotherapy (SC) fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Qingyu Xu, Chendong Wang, Ran You, Bin Leng, Zeyu Yu, Ya Lu, Lingfeng Diao, Hao Jiang, Bei Wu, Guowen Yin
Format: Article
Language:English
Published: Springer 2025-05-01
Series:Discover Oncology
Subjects:
Intrahepatic cholangiocarcinoma
Lenvatinib
PD-1 inhibitor
Hepatic arterial infusion chemotherapy
Systemic chemotherapy
Online Access:https://doi.org/10.1007/s12672-025-02397-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-02397-3

Similar Items